The impact of acid suppression medications and non-steroidal anti-inflammatory drugs on clinical and histologic features in celiac disease. Issue 8 (August 2017)

• Record Type: Journal Article
• Authors: Jordan, Robyn; Shannahan, Sarah; Lewis, Suzanne K.; Krishnareddy, Suneeta; Leffler, Daniel A.; Green, Peter H.R.; Lebwohl, Benjamin
• Is Part Of: Digestive and liver disease. Volume 49:Issue 8(2017)
• Page Start: 883
• Page End: 886
• Publication Date: 2017-08
• Subjects: Celiac disease -- Non-steroidal anti-inflammatory agents -- Proton pump inhibitors; Digestive organs -- Diseases -- Periodicals; Liver -- Diseases -- Periodicals; 616.33005
• DOI: 10.1016/j.dld.2017.03.018
• Languages: English
• ISSNs: 1590-8658

Abstract

Abstract: Introduction: The prevalence of celiac disease (CD) in the US has increased in past decades, as has use of proton pump inhibitors (PPIs), histamine-2-receptor antagonists (H2RAs), aspirin (ASA) and nonsteroidal anti-inflammatory drugs (NSAIDs). We aimed to measure the association between medication use and distribution of villous flattening (VF) among newly diagnosed CD patients. Methods: We performed a cross-sectional study of adult patients with newly-diagnosed CD at two institutions. We collected data on regular use of these medications, clinical presentation, CD serologic status, and distribution of VF. We compared current ASA/NSAID users to non-users, and current PPI/H2RA users to non-users, with regard to these clinical characteristics. Results: Of 148 patients with newly-diagnosed CD, current users of ASA/NSAIDs were older than non-users (47 vs 39 years, p = 0.003) and users of PPI/H2RAs were older than non-users (48 vs 39 years, p = 0.004). PPI/H2RA users comprised 12% of seropositive patients, compared to 55% of seronegative patients (p < 0.01). Patient gender and distribution of villous flattening in the bulb and distal duodenum did not differ by PPI/H2RA or ASA/NSAID use. Conclusions: PPI/H2RA use was associated with seronegative CD. Given the effect of these medications on gastric milieu, the impact of these drugs on presentation and course of CD deserves further investigation.